Browse our anti-p65 (NFkBP65) Antibodies

Full name:
anti-Nuclear Factor-KB P65 Antibodies (NFkBP65)
On www.antibodies-online.com are 1229 Nuclear Factor-KB P65 (NFkBP65) Antibodies from 41 different suppliers available. Additionally we are shipping p65 Kits (102) and p65 Proteins (19) and many more products for this protein. A total of 1417 p65 products are currently listed.
Synonyms:
NFkB, NFKB3, p65
list all antibodies Gene Name GeneID UniProt
NFkBP65 5970 Q04206
NFkBP65 309165  
NFkBP65 19697 Q04207

Show all species

Show all synonyms

All available anti-p65 Antibodies

Go to our pre-filtered search.

Top referenced anti-p65 Antibodies

  1. Human Polyclonal p65 Primary Antibody for EIA, WB - ABIN358921 : Peeters, Palmans, Veld, Scheijen, Heise, Meijer: Cascade synthesis of chiral block copolymers combining lipase catalyzed ring opening polymerization and atom transfer radical polymerization. in Biomacromolecules 2004 (PubMed)
    Show all 5 references for 358921

  2. Human Polyclonal p65 Primary Antibody for IHC, ELISA - ABIN1531923 : Shen, Zhao, Zeng, Yan, Chen, Leng, Mu, Zhang: Inhibition of Pim-1 kinase ameliorates dextran sodium sulfate-induced colitis in mice. in Digestive diseases and sciences 2012 (PubMed)
    Show all 3 references for 1531923

  3. Human Polyclonal p65 Primary Antibody for IHC, ELISA - ABIN1532020 : Ruben, Dillon, Schreck, Henkel, Chen, Maher, Baeuerle, Rosen: Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. in Science (New York, N.Y.) 1991 (PubMed)
    Show all 2 references for 1532020

  4. Human Polyclonal p65 Primary Antibody for IHC, ELISA - ABIN1531352 : Lyle, Valleley, Sharpe, Hewitt: An alternatively spliced transcript, p65 delta 2, of the gene encoding the p65 subunit of the transcription factor NF-kappa B. in Gene 1994 (PubMed)
    Show all 2 references for 1531352

  5. Human Polyclonal p65 Primary Antibody for IHC, ELISA - ABIN1531926 : Baeuerle, Baltimore: NF-kappa B: ten years after. in Cell 1996 (PubMed)
    Show all 2 references for 1531926

  6. Cow (Bovine) Polyclonal p65 Primary Antibody for IHC, WB - ABIN2779331 : Wittwer, Schmitz: NIK and Cot cooperate to trigger NF-kappaB p65 phosphorylation. in Biochemical and biophysical research communications 2008 (PubMed)

  7. Human Polyclonal p65 Primary Antibody for IHC, WB - ABIN222893 : Rashi-Elkeles, Warnatz, Elkon, Kupershtein, Chobod, Paz, Amstislavskiy, Sultan, Safer, Nietfeld, Lehrach, Shamir, Yaspo, Shiloh: Parallel profiling of the transcriptome, cistrome, and epigenome in the cellular response to ionizing radiation. in Science signaling 2014 (PubMed)

More Antibodies against p65 Interaction Partners

Human Nuclear Factor-KB P65 (NFkBP65) interaction partners

  1. knockdown of RPA2 (show RPA2 Antibodies) promoted formation of the menin (show MEN1 Antibodies)-p65 (show GORASP1 Antibodies) complex and repressed the expression of NF-kappaB (show NFKB1 Antibodies)-mediated genes. RPA2 (show RPA2 Antibodies) expression was induced via an E2F1 (show E2F1 Antibodies)-dependent mechanism in MCF7 and MDA-MB-231 cells treated with NF-kappaB (show NFKB1 Antibodies) activators, TNF-alpha (show TNF Antibodies) or lipopolysaccharide (LPS (show IRF6 Antibodies)).

  2. Consistent with these effects, RelA T505A mice exhibit earlier onset of cancer in the N-nitrosodiethylamine model of hepatocellular carcinoma. These data reveal a critical pathway controlling NF-kappaB (show NFKB1 Antibodies) function in the liver that acts to suppress the tumour-promoting activities of RelA.

  3. NF-kappaB (show NFKB1 Antibodies) RelB (show RELB Antibodies) protein, but not RelA, displayed high expression in Endometrial cancer samples and cell lines.

  4. This study demonstrates for the first time that a prominent pathway of reovirus oncolysis of breast cancer is mediated through NF-kB p65 and that PUMA (show BBC3 Antibodies) upregulation is dependent on NF-kB p65 activation.

  5. Site-differential phosphorylation of RelA/p65 modulates RITA (show ZNF331 Antibodies) sensitivity in cancer cells.

  6. Vaccinia virus K1 inhibited acetylation of the RelA (p65) subunit of NF-kappaB (show NFKB1 Antibodies), a nuclear event known to be required for NF-kappaB (show NFKB1 Antibodies) activation.

  7. Within the nucleus, PKC-theta; catalytic activity maintains the Ser536 phosphorylation on the p65 subunit of NF-kappaB (also known as RelA) and can directly influence chromatin accessibility at transcriptional memory genes by regulating H2B deposition.

  8. A subset of leukemic tumors showed active BCR (show BCR Antibodies) and NF-kappaB (show NFKB1 Antibodies) signaling apparently independent of microenvironmental support. In one of these samples, we identified a novel somatic mutation in RELA (E39Q). This sample was resistant to ibrutinib-mediated inhibition of NF-kappaB (show NFKB1 Antibodies) and apoptosis.

  9. to elucidate the induced activation of lytic pathway by ionizing radiation, irradiated SNU-719 cells were checked for the RelA and RelB (show RELB Antibodies) expression by real-time PCR. RelB (show RELB Antibodies) level showed a dose-dependent enhancement on 2nd and 4th day, whereas only a slight upregulation in RelA is noticed

  10. glatiramer acetate treatment also significantly reduced CD40 (show CD40 Antibodies)-mediated P65 (show GORASP1 Antibodies) phosphorylation in RRMS patients, suggesting that reducing CD40 (show CD40 Antibodies)-mediated p-P65 (show GORASP1 Antibodies) induction may be a general mechanism by which some current therapies modulate Multiple Sclerosis disease.

Pig (Porcine) Nuclear Factor-KB P65 (NFkBP65) interaction partners

  1. TMZ pretreatment effectively reduced the myocardial damage caused by CME via inhibiting the PDCD4 (show PDCD4 Antibodies)/NF-kappaB (show NFKB1 Antibodies)/ TNF-alpha (show TNF Antibodies) pathway in cardiomyocytes.

  2. Transmissible gastroenteritis virus infection activates NF-kappaB (show NFKB1 Antibodies).

  3. Zinc finger nuclease (show DCLRE1C Antibodies) in-embryo editing of the RELA locus generated live born domestic pigs with the warthog RELA orthologue, associated with resilience to African Swine Fever.

  4. SIRT1 (show SIRT1 Antibodies), p53 (show TP53 Antibodies) and NF-kappaB (show NFKB1 Antibodies) are involved in the control of both the proliferation and the apoptosis of ovarian cells.

  5. Porcine Coro1A (show CORO1A Antibodies) is an important immunity related gene that helps to inhibit NF-kB activation during H. parasuis infection.

  6. We propose that the variation in RELA identified between the warthog and domestic pig has the potential to underlie the difference between tolerance and rapid death upon African swine fever virus infection.

  7. The characterization of porcine NF-kappaB (show NFKB1 Antibodies) p65 (show SYT1 Antibodies) subunit (pp65 (show LCP1 Antibodies)), is reported.

  8. Viral non-structural protein 1 suppressed host TNF-alpha (show TNF Antibodies) promoter by inhibiting NF-kappaB (show NFKB1 Antibodies) and Sp1 (show SP1 Antibodies) promoter binding activity.

Cow (Bovine) Nuclear Factor-KB P65 (NFkBP65) interaction partners

  1. Hepatic SREBP-1c (show SREBF1 Antibodies)-mediated lipid synthesis and the NF-kappaB (show NFKB1 Antibodies) inflammatory pathway were both overinduced in cows with fatty liver.

  2. Cytopathic bovine viral diarrhea virus strain induces immune marker production in bovine cells through the NF-kappaB (show NFKB1 Antibodies) signaling pathway.

  3. The role of NF-kappaB (show NFKB1 Antibodies) and C/EBP (show CEBPA Antibodies) factors in regulating basal and pathogen-induced expression of both genes from cattle, is investigated.

  4. Altering the extracellular matrix to promote p38 (show MAPK14 Antibodies) activation in cells on fibronectin (show FN1 Antibodies) suppresses NF-kappaB (show NFKB1 Antibodies) activation, suggesting a novel therapeutic strategy for treating

  5. full length coding sequence of the cattle transcription factor p65 was isolated and cloned

  6. the pathogen causing subclinical mastitis impairs NF-kappaB (show NFKB1 Antibodies) activation in MEC (show CCL28 Antibodies) thereby severely weakening the immune response,induction of IL-8 (show IL8 Antibodies) and TNFalpha (show TNF Antibodies), in the udder

  7. These results confirm that VEGI (show TNFSF15 Antibodies) utilizes NF-kappaB (show NFKB1 Antibodies) as a pro-survival role factor in endothelial cells.

Mouse (Murine) Nuclear Factor-KB P65 (NFkBP65) interaction partners

  1. work reveals that simulated microgravity promotes the apoptotic response through a combined modulation of the Uev1A/TICAM/TRAF (show TRAF1 Antibodies)/NF-kappaB (show NFKB1 Antibodies)-regulated apoptosis and the p53 (show TP53 Antibodies)/PCNA (show PCNA Antibodies)- and ATM (show ATM Antibodies)/ATR (show ATR Antibodies)-Chk1 (show CHEK1 Antibodies)/2-controlled DNA-damage response pathways.

  2. This study suggests that mTOR (show FRAP1 Antibodies) activity in hepatocytes decreases hepatic vulnerability to injury through a mechanism dependent on NF-kappaB (show NFKB1 Antibodies) proinflammatory cytokine signaling pathway in both normal and steatotic liver.

  3. this study demonstrates that lipopolysaccharides, TNF-alpha (show TNF Antibodies), and viral infection, all of which induce robust inflammatory responses in naturally differentiated cells, failed to activate NF-kappaB (show NFKB1 Antibodies), the key transcription factor that mediates inflammatory responses, and were unable to induce the expression of inflammatory genes in mouse embryonic stem cells. Similar results were obtained in human embryonic

  4. this study illustrates a significant role of RelA in mediating the corneal neovascularization

  5. Consistent with these effects, RelA T505A mice exhibit earlier onset of cancer in the N-nitrosodiethylamine model of hepatocellular carcinoma. These data reveal a critical pathway controlling NF-kappaB (show NFKB1 Antibodies) function in the liver that acts to suppress the tumour-promoting activities of RelA.

  6. blockage of NF-kappaB (show NFKB1 Antibodies) p65 and/or MAPK p38 (show MAPK1 Antibodies) with their specific inhibitors strongly attenuated B7-H3 (show CD276 Antibodies)-amplified inflammatory response with significantly reduced proinflammatory cytokine and chemokine (show CCL1 Antibodies) production, and markedly ameliorated B7-H3 (show CD276 Antibodies)-exacerbated disruption of blood-brain barrier and severity of disease status in S. pneumoniae-infected mice.

  7. our data show that Substance P (SP) treatment might be associated with anti-inflammatory effects in LPS (show TLR4 Antibodies)-stimulated RAW 264.7 cells by suppressing NF-kappaB (show NFKB1 Antibodies) (p65)activation and inducing HO-1 (show HMOX1 Antibodies) expression.

  8. this study shows that LPS (show TLR4 Antibodies)-induced pro-inflammatory cytokine production is ameliorated in p65-deficient bone marrow-derived macrophages; however, p65-deficient 'activated' peritoneal macrophages exhibited elevated IL-1beta (show IL1B Antibodies) and IL-6 (show IL6 Antibodies)

  9. tis (show PDCD4 Antibodies) study reveals the role of NF-kB signaling pathway in otitis media pathogenesis, and more specifically in mucosal proliferation

  10. Cardiac myocyte subpopulations differ in their NF-kappaB (show NFKB1 Antibodies) subcellular localization and identify the cis (show CISH Antibodies)-Golgi as a cardiac myocyte-specific host compartment.

p65 (NFkBP65) Antigen Profile

Antigen Summary

NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene.

Alternative names and synonyms associated with p65 (NFkBP65)

  • v-rel avian reticuloendotheliosis viral oncogene homolog A (RELA) antibody
  • v-rel avian reticuloendotheliosis viral oncogene homolog A (Rela) antibody
  • v-rel reticuloendotheliosis viral oncogene homolog A (avian) (RELA) antibody
  • v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela) antibody
  • NFkB antibody
  • NFKB3 antibody
  • p65 antibody

Protein level used designations for NFkBP65

NF-kappa-B p65delta3 , nuclear factor NF-kappa-B p65 subunit , nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 , transcription factor p65 , v-rel reticuloendotheliosis viral oncogene homolog A , nuclear factor kappa B subunit p65 , NF-kB p65 subunit , NF-kappaB transcription factor p65 subunit , v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappa light polypeptide gene enhancer in B-cells 3, p65 , avian reticuloendotheliosis viral (v-rel) oncogene homolog A , p65 NF kappaB , p65 NF-kappa B , p65 NFkB

GENE ID SPECIES
5970 Homo sapiens
309165 Rattus norvegicus
396027 Gallus gallus
100135665 Sus scrofa
508233 Bos taurus
19697 Mus musculus
100724366 Cavia porcellus
483729 Canis lupus familiaris
Selected quality suppliers for anti-p65 (NFkBP65) Antibodies
Did you look for something else?